TherapeuticsMD (TXMD) Competitors $1.17 -0.01 (-0.85%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$1.17 0.00 (0.00%) As of 07/14/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TXMD vs. IFRX, KRON, AVTX, ABVC, CUE, GANX, ATRA, RNXT, RENB, and ZIVOShould you be buying TherapeuticsMD stock or one of its competitors? The main competitors of TherapeuticsMD include InflaRx (IFRX), Kronos Bio (KRON), Avalo Therapeutics (AVTX), ABVC BioPharma (ABVC), Cue Biopharma (CUE), Gain Therapeutics (GANX), Atara Biotherapeutics (ATRA), RenovoRx (RNXT), Renovaro (RENB), and ZIVO Bioscience (ZIVO). These companies are all part of the "pharmaceutical products" industry. TherapeuticsMD vs. Its Competitors InflaRx Kronos Bio Avalo Therapeutics ABVC BioPharma Cue Biopharma Gain Therapeutics Atara Biotherapeutics RenovoRx Renovaro ZIVO Bioscience TherapeuticsMD (NASDAQ:TXMD) and InflaRx (NASDAQ:IFRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Which has better earnings & valuation, TXMD or IFRX? TherapeuticsMD has higher revenue and earnings than InflaRx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTherapeuticsMD$1.76M7.69-$2.18MN/AN/AInflaRx$180K332.67-$49.85M-$0.82-1.09 Is TXMD or IFRX more profitable? InflaRx has a net margin of 0.00% compared to TherapeuticsMD's net margin of -114.07%. TherapeuticsMD's return on equity of -7.86% beat InflaRx's return on equity.Company Net Margins Return on Equity Return on Assets TherapeuticsMD-114.07% -7.86% -5.46% InflaRx N/A -64.17%-53.39% Do insiders & institutionals believe in TXMD or IFRX? 30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 42.4% of InflaRx shares are held by institutional investors. 2.3% of TherapeuticsMD shares are held by company insiders. Comparatively, 16.3% of InflaRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts prefer TXMD or IFRX? InflaRx has a consensus target price of $6.60, indicating a potential upside of 639.91%. Given InflaRx's stronger consensus rating and higher probable upside, analysts clearly believe InflaRx is more favorable than TherapeuticsMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TherapeuticsMD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InflaRx 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer TXMD or IFRX? In the previous week, InflaRx had 6 more articles in the media than TherapeuticsMD. MarketBeat recorded 7 mentions for InflaRx and 1 mentions for TherapeuticsMD. TherapeuticsMD's average media sentiment score of 1.87 beat InflaRx's score of 0.65 indicating that TherapeuticsMD is being referred to more favorably in the media. Company Overall Sentiment TherapeuticsMD Very Positive InflaRx Positive Which has more volatility and risk, TXMD or IFRX? TherapeuticsMD has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, InflaRx has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. SummaryInflaRx beats TherapeuticsMD on 9 of the 14 factors compared between the two stocks. Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TXMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXMD vs. The Competition Export to ExcelMetricTherapeuticsMDMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.54M$2.42B$5.54B$9.14BDividend YieldN/A1.70%5.01%4.00%P/E RatioN/A9.1928.6919.45Price / Sales7.69461.68372.4779.78Price / CashN/A22.3424.7227.47Price / Book0.494.708.215.58Net Income-$2.18M$30.99M$3.19B$252.81M7 Day Performance-0.85%3.04%3.60%2.11%1 Month PerformanceN/A22.83%9.61%11.87%1 Year Performance-35.36%-3.74%30.04%16.61% TherapeuticsMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXMDTherapeuticsMD0.4458 of 5 stars$1.17-0.8%N/A-36.8%$13.54M$1.76M0.00420Positive NewsIFRXInflaRx2.7429 of 5 stars$0.82+2.2%$6.60+704.9%-45.3%$53.87M$180K-1.0060High Trading VolumeKRONKronos Bio2.8039 of 5 stars$0.88+1.5%$1.63+84.7%-38.5%$53.72M$9.85M-0.82100AVTXAvalo Therapeutics3.1524 of 5 stars$4.75-4.2%$30.00+531.6%-59.7%$53.71M$440K0.0040ABVCABVC BioPharma0.4106 of 5 stars$3.99+28.3%N/A+343.7%$52.81M$510K-30.6930High Trading VolumeCUECue Biopharma4.0734 of 5 stars$0.70+0.7%$3.00+328.4%-17.4%$52.38M$9.29M-1.0560GANXGain Therapeutics2.3748 of 5 stars$1.60-5.3%$8.20+412.5%+34.8%$50.61M$50K-1.8620ATRAAtara Biotherapeutics4.472 of 5 stars$8.58+1.3%$17.75+106.9%-11.2%$50.46M$128.94M-2.31330News CoverageRNXTRenovoRx2.5282 of 5 stars$1.32-2.9%$7.25+449.2%+8.4%$49.74M$240K-3.306News CoverageRENBRenovaro1.9031 of 5 stars$0.30+2.6%N/A-80.7%$49.72MN/A-0.3920Gap UpZIVOZIVO BioscienceN/A$13.00+8.4%N/A+59.8%$49.62M$15.85K-2.6610 Related Companies and Tools Related Companies InflaRx Alternatives Kronos Bio Alternatives Avalo Therapeutics Alternatives ABVC BioPharma Alternatives Cue Biopharma Alternatives Gain Therapeutics Alternatives Atara Biotherapeutics Alternatives RenovoRx Alternatives Renovaro Alternatives ZIVO Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TXMD) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXMD Stock Alerts